Pancreatic cancer cells. Anne Weston, Francis Crick Institute. Pancreatic cancer cells. Credit: Anne Weston, Francis Crick Institute.
Pancreatic cancer cells. Anne Weston, Francis Crick Institute. Pancreatic cancer cells. Credit: Anne Weston, Francis Crick Institute. A 'tumour-busting' drug developed at UCL, which scientists say could improve the outlook for people with pancreatic cancer, is set to be trialled in patients following U.S regulatory approval. Pancreatic cancer is one of the most lethal forms of cancer, with a five-year survival rate of less than 8%, according to data from Public Health England. In the UK alone, approximately 11,000 new cases are diagnosed annually.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
